Eloxx Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$36,065,000 over the previous period. Total operating expenses were $34,419,000.
Profit Margin
| 2012 | 200K | -5.06M | -2533.07% |
|---|---|---|---|
| 2013 | 0 | -6.12M | |
| 2015 | 75K | -18.06M | -24085.05% |
| 2016 | 75K | -8.26M | -11023.91% |
| 2017 | 0 | -21.21M | |
| 2018 | 0 | -47.18M | |
| 2019 | 0 | -50.87M | |
| 2020 | 0 | -34.57M | |
| 2021 | 0 | -66.72M | |
| 2022 | 0 | -36.06M |
ELOX Income Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 75K | 75K | 0 | 200K |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 75K | 75K | 0 | 200K |
Operating exp. | ||||||||||
Research and development | 23.72M | 45.56M | 14.59M | 26.34M | 20.48M | 16.39M | 2.18M | 4.56M | 2.08M | 2.56M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 34.41M | 66.01M | 29.43M | 50.55M | 46.97M | 19.1M | 3.78M | 7.73M | 4.58M | 5.29M |
Operating income | -34.41M | -66.01M | -33.45M | -50.55M | -47.56M | -20.39M | -11.19M | -18.07M | -4.65M | -5.09M |
Other income (expenses), net | 29K | 542K | -1.12M | 225K | -686K | -824K | 2.24M | 12.95K | -1.41M | 151.32K |
Income before tax | -36.06M | -66.72M | -34.57M | -50.87M | -47.06M | -21.21M | -8.94M | -18.06M | -6.12M | 0 |
Income tax expense | 2.02M | 1.25M | 1.40M | 1.61M | 122K | 43K | -680K | 2.76K | 3.07M | 0 |
Net income | -36.06M | -66.72M | -34.57M | -50.87M | -47.18M | -21.21M | -8.26M | -18.06M | -6.12M | -5.06M |
Earnings per share | ||||||||||
Basic EPS | -16.65 | -38.15 | -34.47 | -53.46 | -58.19 | -170.52 | -325.47 | -1.00K | -3.58K | -189.16K |
Diluted EPS | -16.65 | -38.15 | -34.47 | -53.46 | -58.19 | -170.52 | -325.47 | -1.00K | -3.58K | -189.16K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |